Novartis granted injunctions against four other generic makers over Galvus
Novartis filed an RTI with the DCGI seeking information regarding regulatory approvals issued for Vildagliptin
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.